Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation is a research paper published in Journal of Allergy and Clinical Immunology (2023). On theSindex it has a DataRank of 0.614. It has been cited 59 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.614
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: K23 AI163371
NIMHD NIH HHS
Grant: K99 MD015767
NHLBI NIH HHS
Grant: L30 HL165481
NIMHD NIH HHS
Grant: R00 MD015767
NIA NIH HHS
Grant: K24 AG049036
NHLBI NIH HHS
Grant: K01 HL145320
NHLBI NIH HHS
Grant: K23 HL161332
FWCI
8.17
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals